Deal, United Kingdom

Clive Mason


Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 82(Granted Patents)


Location History:

  • Sandwich, GB (2004)
  • Deal, GB (2005 - 2009)

Company Filing History:


Years Active: 2004-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Clive Mason: Innovator in Pharmaceutical Compounds

Introduction

Clive Mason is a notable inventor based in Deal, GB, recognized for his contributions to the field of pharmaceutical innovations. With a total of five patents to his name, Mason has made significant strides in developing compounds that address critical health issues.

Latest Patents

Mason's latest patents include the invention of triamide-substituted heterobicyclic compounds. These compounds are identified as triamide MTP/ApoB inhibitors, which are useful for the treatment of obesity and lipid disorders. The invention details the formula wherein R-R are defined in the specification, along with pharmaceutical compositions and processes for preparing these compounds. This innovative work highlights Mason's commitment to advancing medical treatments.

Career Highlights

Clive Mason is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on developing groundbreaking solutions that can improve patient outcomes. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Mason has collaborated with notable colleagues, including Peter Bertinato and Brian S Bronk. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their work in the pharmaceutical sector.

Conclusion

Clive Mason's contributions to the field of pharmaceutical compounds demonstrate his dedication to innovation and improving health outcomes. His work continues to influence the development of effective treatments for obesity and lipid disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…